首页 > 最新文献

JMIR Cardio最新文献

英文 中文
A Smartwatch System for Continuous Monitoring of Atrial Fibrillation in Older Adults After Stroke or Transient Ischemic Attack: Application Design Study. 用于连续监测老年人中风或短暂性脑缺血发作后房颤的智能手表系统:应用设计研究
Q2 Medicine Pub Date : 2023-02-13 DOI: 10.2196/41691
Dong Han, Eric Y Ding, Chaeho Cho, Haewook Jung, Emily L Dickson, Fahimeh Mohagheghian, Andrew G Peitzsch, Danielle DiMezza, Khanh-Van Tran, David D McManus, Ki H Chon

Background: The prevalence of atrial fibrillation (AF) increases with age and can lead to stroke. Therefore, older adults may benefit the most from AF screening. However, older adult populations tend to lag more than younger groups in the adoption of, and comfort with, the use of mobile health (mHealth) apps. Furthermore, although mobile apps that can detect AF are available to the public, most are designed for intermittent AF detection and for younger users. No app designed for long-term AF monitoring has released detailed system design specifications that can handle large data collections, especially in this age group.

Objective: This study aimed to design an innovative smartwatch-based AF monitoring mHealth solution in collaboration with older adult participants and clinicians.

Methods: The Pulsewatch system is designed to link smartwatches and smartphone apps, a website for data verification, and user data organization on a cloud server. The smartwatch in the Pulsewatch system is designed to continuously monitor the pulse rate with embedded AF detection algorithms, and the smartphone in the Pulsewatch system is designed to serve as the data-transferring hub to the cloud storage server.

Results: We implemented the Pulsewatch system based on the functionality that patients and caregivers recommended. The user interfaces of the smartwatch and smartphone apps were specifically designed for older adults at risk for AF. We improved our Pulsewatch system based on feedback from focus groups consisting of patients with stroke and clinicians. The Pulsewatch system was used by the intervention group for up to 6 weeks in the 2 phases of our randomized clinical trial. At the conclusion of phase 1, 90 trial participants who had used the Pulsewatch app and smartwatch for 14 days completed a System Usability Scale to assess the usability of the Pulsewatch system; of 88 participants, 56 (64%) endorsed that the smartwatch app is "easy to use." For phases 1 and 2 of the study, we collected 9224.4 hours of smartwatch recordings from the participants. The longest recording streak in phase 2 was 21 days of consecutive recordings out of the 30 days of data collection.

Conclusions: This is one of the first studies to provide a detailed design for a smartphone-smartwatch dyad for ambulatory AF monitoring. In this paper, we report on the system's usability and opportunities to increase the acceptability of mHealth solutions among older patients with cognitive impairment.

Trial registration: ClinicalTrials.gov NCT03761394; https://www.clinicaltrials.gov/ct2/show/NCT03761394.

International registered report identifier (irrid): RR2-10.1016/j.cvdhj.2021.07.002.

背景:房颤(AF)的患病率随着年龄的增长而增加,并可导致中风。因此,老年人可能从房颤筛查中获益最多。然而,老年人在接受和使用移动医疗(mHealth)应用程序方面往往落后于年轻人。此外,虽然可以检测自动对焦的移动应用程序可供公众使用,但大多数都是为间歇性自动对焦检测和年轻用户设计的。没有任何专为长期AF监测而设计的应用程序发布了详细的系统设计规范,可以处理大量数据收集,特别是在这个年龄段。目的:本研究旨在与老年参与者和临床医生合作,设计一种创新的基于智能手表的AF监测移动健康解决方案。方法:Pulsewatch系统将智能手表与智能手机应用程序、数据验证网站和用户数据组织在云服务器上进行链接。Pulsewatch系统中的智能手表旨在通过嵌入式自动对焦检测算法持续监测脉搏率,而Pulsewatch系统中的智能手机则被设计为云存储服务器的数据传输枢纽。结果:我们根据患者和护理人员推荐的功能实现了Pulsewatch系统。智能手表和智能手机应用程序的用户界面是专门为有AF风险的老年人设计的。我们根据由中风患者和临床医生组成的焦点小组的反馈改进了Pulsewatch系统。在我们的随机临床试验的两个阶段中,干预组使用Pulsewatch系统长达6周。在第1阶段结束时,90名使用Pulsewatch应用程序和智能手表14天的试验参与者完成了系统可用性量表,以评估Pulsewatch系统的可用性;在88名参与者中,56人(64%)认为智能手表应用程序“易于使用”。在研究的第一阶段和第二阶段,我们从参与者那里收集了9224.4小时的智能手表记录。第2阶段最长的连续记录是在30天的数据收集中连续记录了21天。结论:这是第一个为动态房颤监测的智能手机-智能手表系统提供详细设计的研究之一。在本文中,我们报告了该系统的可用性和机会,以提高老年认知障碍患者对移动健康解决方案的可接受性。试验注册:ClinicalTrials.gov NCT03761394;https://www.clinicaltrials.gov/ct2/show/NCT03761394.International注册报告标识符(irrid): RR2-10.1016/j.cvdhj.2021.07.002。
{"title":"A Smartwatch System for Continuous Monitoring of Atrial Fibrillation in Older Adults After Stroke or Transient Ischemic Attack: Application Design Study.","authors":"Dong Han,&nbsp;Eric Y Ding,&nbsp;Chaeho Cho,&nbsp;Haewook Jung,&nbsp;Emily L Dickson,&nbsp;Fahimeh Mohagheghian,&nbsp;Andrew G Peitzsch,&nbsp;Danielle DiMezza,&nbsp;Khanh-Van Tran,&nbsp;David D McManus,&nbsp;Ki H Chon","doi":"10.2196/41691","DOIUrl":"https://doi.org/10.2196/41691","url":null,"abstract":"<p><strong>Background: </strong>The prevalence of atrial fibrillation (AF) increases with age and can lead to stroke. Therefore, older adults may benefit the most from AF screening. However, older adult populations tend to lag more than younger groups in the adoption of, and comfort with, the use of mobile health (mHealth) apps. Furthermore, although mobile apps that can detect AF are available to the public, most are designed for intermittent AF detection and for younger users. No app designed for long-term AF monitoring has released detailed system design specifications that can handle large data collections, especially in this age group.</p><p><strong>Objective: </strong>This study aimed to design an innovative smartwatch-based AF monitoring mHealth solution in collaboration with older adult participants and clinicians.</p><p><strong>Methods: </strong>The Pulsewatch system is designed to link smartwatches and smartphone apps, a website for data verification, and user data organization on a cloud server. The smartwatch in the Pulsewatch system is designed to continuously monitor the pulse rate with embedded AF detection algorithms, and the smartphone in the Pulsewatch system is designed to serve as the data-transferring hub to the cloud storage server.</p><p><strong>Results: </strong>We implemented the Pulsewatch system based on the functionality that patients and caregivers recommended. The user interfaces of the smartwatch and smartphone apps were specifically designed for older adults at risk for AF. We improved our Pulsewatch system based on feedback from focus groups consisting of patients with stroke and clinicians. The Pulsewatch system was used by the intervention group for up to 6 weeks in the 2 phases of our randomized clinical trial. At the conclusion of phase 1, 90 trial participants who had used the Pulsewatch app and smartwatch for 14 days completed a System Usability Scale to assess the usability of the Pulsewatch system; of 88 participants, 56 (64%) endorsed that the smartwatch app is \"easy to use.\" For phases 1 and 2 of the study, we collected 9224.4 hours of smartwatch recordings from the participants. The longest recording streak in phase 2 was 21 days of consecutive recordings out of the 30 days of data collection.</p><p><strong>Conclusions: </strong>This is one of the first studies to provide a detailed design for a smartphone-smartwatch dyad for ambulatory AF monitoring. In this paper, we report on the system's usability and opportunities to increase the acceptability of mHealth solutions among older patients with cognitive impairment.</p><p><strong>Trial registration: </strong>ClinicalTrials.gov NCT03761394; https://www.clinicaltrials.gov/ct2/show/NCT03761394.</p><p><strong>International registered report identifier (irrid): </strong>RR2-10.1016/j.cvdhj.2021.07.002.</p>","PeriodicalId":14706,"journal":{"name":"JMIR Cardio","volume":"7 ","pages":"e41691"},"PeriodicalIF":0.0,"publicationDate":"2023-02-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9972205/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10803585","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Remotely Delivered Cardiac Rehabilitation Exercise for Coronary Heart Disease: Nonrandomized Feasibility Study. 冠心病远程心脏康复训练:非随机可行性研究
Q2 Medicine Pub Date : 2023-02-10 DOI: 10.2196/40283
Oonagh M Giggins, Julie Doyle, Suzanne Smith, Grainne Vavasour, Orla Moran, Shane Gavin, Nisanth Sojan, Gordon Boyle

Background: Exercise-based cardiac rehabilitation (CR) is recommended for coronary heart disease (CHD). However, poor uptake of and poor adherence to CR exercise programs have been reported globally. Delivering CR exercise classes remotely may remove some of the barriers associated with traditional hospital- or center-based CR.

Objective: We have developed a bespoke platform, Eastern Corridor Medical Engineering Centre-Cardiac Rehabilitation (ECME-CR), to support remotely delivered CR exercise. This pilot trial sought to test the ECME-CR platform and examine the efficacy and feasibility of a remote CR exercise program compared to a traditional center-based program.

Methods: In all, 21 participants with CHD were recruited and assigned to either the intervention or control group. Both groups performed the same 8-week exercise program. Participants in the intervention group took part in web-based exercise classes and used the ECME-CR platform during the intervention period, whereas participants in the control group attended in-person classes. Outcomes were assessed at baseline and following the 8-week intervention period. The primary outcome measure was exercise capacity, assessed using a 6-minute walk test (6MWT). Secondary outcomes included measurement of grip strength, self-reported quality of life, heart rate, blood pressure, and body composition. A series of mixed between-within subjects ANOVA were conducted to examine the mean differences in study outcomes between and within groups. Participant adherence to the exercise program was also analyzed.

Results: In all, 8 participants (male: n=5; age: mean 69.7, SD 7.2 years; height: mean 163.9, SD 5.4 cm; weight: mean 81.6, SD 14.1 kg) in the intervention group and 9 participants (male: n=9; age: mean 69.8, SD 8.2 years; height: mean 173.8, SD 5.2 cm; weight: mean 94.4, SD 18.0 kg) in the control group completed the exercise program. Although improvements in 6MWT distance were observed from baseline to follow-up in both the intervention (mean 490.1, SD 80.2 m to mean 504.5, SD 93.7 m) and control (mean 510.2, SD 48.3 m to mean 520.6, SD 49.4 m) group, no significant interaction effect (F1,14=.026; P=.87) nor effect for time (F1,14=2.51; P=.14) were observed. No significant effects emerged for any of the other secondary end points (all P>.0275). Adherence to the exercise program was high in both the intervention (14.25/16, 89.1%) and control (14.33/16, 89.6%) group. No adverse events or safety issues were reported in either group during the study.

Conclusions: This pilot trial did not show evidence of significant positive effect for either the remotely delivered or center-based program. The 6MWT may not have been sufficiently sensitive to identify a change in this cohort of participants with stable CHD. This trial does provide evidence that remote CR exercise, supporte

背景:以运动为基础的心脏康复(CR)被推荐用于治疗冠心病(CHD)。然而,在全球范围内,对CR运动计划的不良吸收和不良依从性都有报道。远程提供CR运动课程可以消除传统医院或中心CR相关的一些障碍。目的:我们开发了一个定制平台,东部走廊医学工程中心心脏康复(ECME-CR),以支持远程提供CR运动。该试点试验旨在测试ECME-CR平台,并与传统的基于中心的计划相比,检查远程CR锻炼计划的有效性和可行性。方法:总共招募了21名冠心病患者,并将其分为干预组和对照组。两组都进行了相同的8周锻炼计划。干预组参与者在干预期间参加基于网络的运动课程并使用ECME-CR平台,而对照组参与者则参加面对面的课程。在基线和8周干预期后评估结果。主要结局指标是运动能力,通过6分钟步行测试(6MWT)进行评估。次要结果包括握力、自我报告的生活质量、心率、血压和身体成分的测量。进行了一系列混合的受试者间方差分析,以检查组间和组内研究结果的平均差异。参与者对锻炼计划的坚持程度也进行了分析。结果:共有8名参与者(男性:n=5;年龄:平均69.7岁,SD 7.2岁;身高:平均163.9,标准差5.4 cm;体重:平均81.6,SD 14.1 kg)干预组和9名参与者(男性:n=9;年龄:平均69.8岁,标准差8.2岁;身高:平均173.8,标准差5.2 cm;体重:平均94.4,标准差18.0 kg),对照组完成运动方案。虽然干预组(平均490.1 m, SD 80.2 m至平均504.5 m, SD 93.7 m)和对照组(平均510.2 m, SD 48.3 m至平均520.6 m, SD 49.4 m)从基线到随访均观察到6MWT距离的改善,但没有显著的相互作用效应(F1,14= 0.026;P= 0.87)与时间无关(F1,14=2.51;P=.14)。其他次要终点均无显著影响(P均> 0.0275)。干预组(14.25/16,89.1%)和对照组(14.33/16,89.6%)对运动计划的坚持度都很高。在研究期间,两组均未报告不良事件或安全问题。结论:该试点试验没有显示出远程交付或中心项目显著的积极影响的证据。6MWT可能不够敏感,无法识别这组稳定型冠心病患者的变化。这项试验确实提供了证据,证明在数字自我监控的支持下,远程CR锻炼是可行的,可以考虑为不太可能参与传统中心项目的个人提供支持。国际注册报告标识符(irrid): RR2-10.2196/31855。
{"title":"Remotely Delivered Cardiac Rehabilitation Exercise for Coronary Heart Disease: Nonrandomized Feasibility Study.","authors":"Oonagh M Giggins,&nbsp;Julie Doyle,&nbsp;Suzanne Smith,&nbsp;Grainne Vavasour,&nbsp;Orla Moran,&nbsp;Shane Gavin,&nbsp;Nisanth Sojan,&nbsp;Gordon Boyle","doi":"10.2196/40283","DOIUrl":"https://doi.org/10.2196/40283","url":null,"abstract":"<p><strong>Background: </strong>Exercise-based cardiac rehabilitation (CR) is recommended for coronary heart disease (CHD). However, poor uptake of and poor adherence to CR exercise programs have been reported globally. Delivering CR exercise classes remotely may remove some of the barriers associated with traditional hospital- or center-based CR.</p><p><strong>Objective: </strong>We have developed a bespoke platform, Eastern Corridor Medical Engineering Centre-Cardiac Rehabilitation (ECME-CR), to support remotely delivered CR exercise. This pilot trial sought to test the ECME-CR platform and examine the efficacy and feasibility of a remote CR exercise program compared to a traditional center-based program.</p><p><strong>Methods: </strong>In all, 21 participants with CHD were recruited and assigned to either the intervention or control group. Both groups performed the same 8-week exercise program. Participants in the intervention group took part in web-based exercise classes and used the ECME-CR platform during the intervention period, whereas participants in the control group attended in-person classes. Outcomes were assessed at baseline and following the 8-week intervention period. The primary outcome measure was exercise capacity, assessed using a 6-minute walk test (6MWT). Secondary outcomes included measurement of grip strength, self-reported quality of life, heart rate, blood pressure, and body composition. A series of mixed between-within subjects ANOVA were conducted to examine the mean differences in study outcomes between and within groups. Participant adherence to the exercise program was also analyzed.</p><p><strong>Results: </strong>In all, 8 participants (male: n=5; age: mean 69.7, SD 7.2 years; height: mean 163.9, SD 5.4 cm; weight: mean 81.6, SD 14.1 kg) in the intervention group and 9 participants (male: n=9; age: mean 69.8, SD 8.2 years; height: mean 173.8, SD 5.2 cm; weight: mean 94.4, SD 18.0 kg) in the control group completed the exercise program. Although improvements in 6MWT distance were observed from baseline to follow-up in both the intervention (mean 490.1, SD 80.2 m to mean 504.5, SD 93.7 m) and control (mean 510.2, SD 48.3 m to mean 520.6, SD 49.4 m) group, no significant interaction effect (F<sub>1,14</sub>=.026; P=.87) nor effect for time (F<sub>1,14</sub>=2.51; P=.14) were observed. No significant effects emerged for any of the other secondary end points (all P>.0275). Adherence to the exercise program was high in both the intervention (14.25/16, 89.1%) and control (14.33/16, 89.6%) group. No adverse events or safety issues were reported in either group during the study.</p><p><strong>Conclusions: </strong>This pilot trial did not show evidence of significant positive effect for either the remotely delivered or center-based program. The 6MWT may not have been sufficiently sensitive to identify a change in this cohort of participants with stable CHD. This trial does provide evidence that remote CR exercise, supporte","PeriodicalId":14706,"journal":{"name":"JMIR Cardio","volume":"7 ","pages":"e40283"},"PeriodicalIF":0.0,"publicationDate":"2023-02-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9960022/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10774144","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
The Impact and Perception of England's Web-Based Heart Age Test of Cardiovascular Disease Risk: Mixed Methods Study. 英国基于网络的心血管疾病风险心脏年龄测试的影响和感知:混合方法研究
Q2 Medicine Pub Date : 2023-02-06 DOI: 10.2196/39097
Victoria Riley, Christopher Gidlow, Sophia Fedorowicz, Catherine Lagord, Katherine Thompson, Joshua Woolner, Rosie Taylor, Jade Clark, Andrew Lloyd-Harris

Background: It is well documented that individuals struggle to understand cardiovascular disease (CVD) percentage risk scores, which led to the development of heart age as a means of communicating risk. Developed for clinical use, its application in raising public awareness of heart health as part of a self-directed digital test has not been considered previously.

Objective: This study aimed to understand who accesses England's heart age test (HAT) and its effect on user perception, knowledge, and understanding of CVD risk; future behavior intentions; and potential engagement with primary care services.

Methods: There were 3 sources of data: routinely gathered data on all individuals accessing the HAT (February 2015 to June 2020); web-based survey, distributed between January 2021 and March 2021; and interviews with a subsample of survey respondents (February 2021 to March 2021). Data were used to describe the test user population and explore knowledge and understanding of CVD risk, confidence in interpreting and controlling CVD risk, and effect on future behavior intentions and potential engagement with primary care. Interviews were analyzed using reflexive thematic analysis.

Results: Between February 2015 and June 2020, the HAT was completed approximately 5 million times, with more completions by men (2,682,544/4,898,532, 54.76%), those aged between 50 to 59 years (1,334,195/4,898,532, 27.24%), those from White ethnic background (3,972,293/4,898,532, 81.09%), and those living in the least deprived 20% of areas (707,747/4,898,532, 14.45%). The study concluded with 819 survey responses and 33 semistructured interviews. Participants stated that they understood the meaning of high estimated heart age and self-reported at least some improvement in the understanding and confidence in understanding and controlling CVD risk. Negative emotional responses were provoked among users when estimated heart age did not equate to their previous risk perceptions. The limited information needed to complete it or the production of a result when physiological risk factor information was missing (ie, blood pressure and cholesterol level) led some users to question the credibility of the test. However, most participants who were interviewed mentioned that they would recommend or had already recommended the test to others, would use it again in the future, and would be more likely to take up the offer of a National Health Service Health Check and self-reported that they had made or intended to make changes to their health behavior or felt encouraged to continue to make changes to their health behavior.

Conclusions: England's web-based HAT has engaged large number of people in their heart health. Improvements to England's HAT, noted in this paper, may enhance user satisfaction and prevent confusion. Future studies to understand the long-term benefit of the te

背景:有充分的文献表明,个体很难理解心血管疾病(CVD)百分比风险评分,这导致了心脏年龄作为沟通风险的手段的发展。它是为临床使用而开发的,但作为自主数字测试的一部分,在提高公众对心脏健康的认识方面的应用,以前从未被考虑过。目的:本研究旨在了解英国心脏年龄测试(HAT)的使用人群及其对心血管疾病风险感知、知识和理解的影响;未来行为意向;以及潜在的初级保健服务。方法:数据有3个来源:常规收集2015年2月至2020年6月访问HAT的所有个人的数据;基于网络的调查,于2021年1月至2021年3月分发;以及对调查受访者的子样本进行访谈(2021年2月至2021年3月)。数据用于描述测试用户群体,并探讨对心血管疾病风险的认识和理解,对解释和控制心血管疾病风险的信心,以及对未来行为意图和潜在初级保健参与的影响。访谈采用反身性主题分析。结果:2015年2月至2020年6月,HAT完成次数约为500万次,其中男性完成次数较多(2,682,544/4,898,532,54.76%),年龄在50至59岁之间(1,334,195/4,898,532,27.24%),白人背景(3,972,293/4,898,532,81.09%),生活在最贫困的20%地区(707,747/4,898,532,14.45%)。该研究以819份调查回复和33份半结构化访谈结束。参与者表示,他们理解高估计心脏年龄的含义,并自我报告至少在理解和控制心血管疾病风险方面有所改善和信心。当估计的心脏年龄与他们之前的风险认知不相等时,用户会产生负面情绪反应。完成测试所需的有限信息,或者在缺乏生理风险因素信息(如血压和胆固醇水平)的情况下得出结果,导致一些用户质疑测试的可信度。然而,大多数接受采访的参与者提到,他们会推荐或已经推荐给其他人,将来会再次使用它,并且更有可能接受国家健康服务健康检查的提议,并自我报告他们已经或打算改变他们的健康行为,或者感到受到鼓励继续改变他们的健康行为。结论:英国基于网络的HAT已经吸引了大量的人参与他们的心脏健康。本文指出,对英国HAT的改进可以提高用户满意度并防止混淆。未来有必要进行研究,以了解该测试对行为结果的长期益处。
{"title":"The Impact and Perception of England's Web-Based Heart Age Test of Cardiovascular Disease Risk: Mixed Methods Study.","authors":"Victoria Riley,&nbsp;Christopher Gidlow,&nbsp;Sophia Fedorowicz,&nbsp;Catherine Lagord,&nbsp;Katherine Thompson,&nbsp;Joshua Woolner,&nbsp;Rosie Taylor,&nbsp;Jade Clark,&nbsp;Andrew Lloyd-Harris","doi":"10.2196/39097","DOIUrl":"https://doi.org/10.2196/39097","url":null,"abstract":"<p><strong>Background: </strong>It is well documented that individuals struggle to understand cardiovascular disease (CVD) percentage risk scores, which led to the development of heart age as a means of communicating risk. Developed for clinical use, its application in raising public awareness of heart health as part of a self-directed digital test has not been considered previously.</p><p><strong>Objective: </strong>This study aimed to understand who accesses England's heart age test (HAT) and its effect on user perception, knowledge, and understanding of CVD risk; future behavior intentions; and potential engagement with primary care services.</p><p><strong>Methods: </strong>There were 3 sources of data: routinely gathered data on all individuals accessing the HAT (February 2015 to June 2020); web-based survey, distributed between January 2021 and March 2021; and interviews with a subsample of survey respondents (February 2021 to March 2021). Data were used to describe the test user population and explore knowledge and understanding of CVD risk, confidence in interpreting and controlling CVD risk, and effect on future behavior intentions and potential engagement with primary care. Interviews were analyzed using reflexive thematic analysis.</p><p><strong>Results: </strong>Between February 2015 and June 2020, the HAT was completed approximately 5 million times, with more completions by men (2,682,544/4,898,532, 54.76%), those aged between 50 to 59 years (1,334,195/4,898,532, 27.24%), those from White ethnic background (3,972,293/4,898,532, 81.09%), and those living in the least deprived 20% of areas (707,747/4,898,532, 14.45%). The study concluded with 819 survey responses and 33 semistructured interviews. Participants stated that they understood the meaning of high estimated heart age and self-reported at least some improvement in the understanding and confidence in understanding and controlling CVD risk. Negative emotional responses were provoked among users when estimated heart age did not equate to their previous risk perceptions. The limited information needed to complete it or the production of a result when physiological risk factor information was missing (ie, blood pressure and cholesterol level) led some users to question the credibility of the test. However, most participants who were interviewed mentioned that they would recommend or had already recommended the test to others, would use it again in the future, and would be more likely to take up the offer of a National Health Service Health Check and self-reported that they had made or intended to make changes to their health behavior or felt encouraged to continue to make changes to their health behavior.</p><p><strong>Conclusions: </strong>England's web-based HAT has engaged large number of people in their heart health. Improvements to England's HAT, noted in this paper, may enhance user satisfaction and prevent confusion. Future studies to understand the long-term benefit of the te","PeriodicalId":14706,"journal":{"name":"JMIR Cardio","volume":"7 ","pages":"e39097"},"PeriodicalIF":0.0,"publicationDate":"2023-02-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9983813/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9082156","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Patterns in the Use of Heart Failure Telemonitoring: Post Hoc Analysis of the e-Vita Heart Failure Trial. 心衰远程监控的使用模式:e-Vita 心衰试验的事后分析》。
Q2 Medicine Pub Date : 2023-01-31 DOI: 10.2196/41248
Maaike Brons, Iris Ten Klooster, Lisette van Gemert-Pijnen, Tiny Jaarsma, Folkert W Asselbergs, Marish I F J Oerlemans, Stefan Koudstaal, Frans H Rutten

Background: Research on the use of home telemonitoring data and adherence to it can provide new insights into telemonitoring for the daily management of patients with heart failure (HF).

Objective: We described the use of a telemonitoring platform-including remote patient monitoring of blood pressure, pulse, and weight-and the use of the electronic personal health record. Patient characteristics were assessed in both adherent and nonadherent patients to weight transmissions.

Methods: We used the data of the e-Vita HF study, a 3-arm parallel randomized trial performed in stable patients with HF managed in outpatient clinics in the Netherlands. In this study, data were analyzed from the participants in the intervention arm (ie, e-Vita HF platform). Adherence to weight transmissions was defined as transmitting weight ≥3 times per week for at least 42 weeks during a year.

Results: Data from 150 patients (mean age 67, SD 11 years; n=37, 25% female; n=123, 82% self-assessed New York Heart Association class I-II) were analyzed. One-year adherence to weight transmissions was 74% (n=111). Patients adherent to weight transmissions were less often hospitalized for HF in the 6 months before enrollment in the study compared to those who were nonadherent (n=9, 8% vs n=9, 23%; P=.02). The percentage of patients visiting the personal health record dropped steadily over time (n=140, 93% vs n=59, 39% at one year). With univariable analyses, there was no significant correlation between patient characteristics and adherence to weight transmissions.

Conclusions: Adherence to remote patient monitoring was high among stable patients with HF and best for weighing; however, adherence decreased over time. Clinical and demographic variables seem not related to adherence to transmitting weight.

Trial registration: ClinicalTrials.gov NCT01755988; https://clinicaltrials.gov/ct2/show/NCT01755988.

背景:对家庭远程监控数据的使用和遵守情况进行研究可为远程监控对心力衰竭(HF)患者的日常管理提供新的见解:对家庭远程监控数据的使用和遵守情况的研究可为远程监控心衰(HF)患者的日常管理提供新的见解:我们介绍了远程监控平台的使用情况(包括对患者血压、脉搏和体重的远程监控)以及电子个人健康记录的使用情况。我们对坚持和不坚持体重传输的患者特征进行了评估:我们使用了 e-Vita HF 研究的数据,该研究是一项三臂平行随机试验,对象是在荷兰门诊接受治疗的稳定型高血压患者。在这项研究中,我们分析了干预组(即 e-Vita HF 平台)参与者的数据。体重传输的坚持度被定义为一年内每周传输体重≥3次,至少42周:分析了 150 名患者(平均年龄 67 岁,SD 11 岁;n=37,25% 为女性;n=123,82% 自我评估为纽约心脏协会 I-II 级)的数据。一年内坚持体重控制的比例为 74%(n=111)。与未坚持体重控制的患者相比,坚持体重控制的患者在入组前 6 个月因高血压住院的比例较低(9 例,8% vs 9 例,23%;P=.02)。随着时间的推移,访问个人健康记录的患者比例持续下降(一年时为 140 人,93% vs 59 人,39%)。通过单变量分析,患者特征与体重传输的依从性之间没有显著相关性:结论:高血压稳定期患者对远程患者监护的依从性较高,对称重的依从性最好;但随着时间的推移,依从性有所下降。临床和人口统计学变量似乎与体重传输的依从性无关:试验注册:ClinicalTrials.gov NCT01755988;https://clinicaltrials.gov/ct2/show/NCT01755988。
{"title":"Patterns in the Use of Heart Failure Telemonitoring: Post Hoc Analysis of the e-Vita Heart Failure Trial.","authors":"Maaike Brons, Iris Ten Klooster, Lisette van Gemert-Pijnen, Tiny Jaarsma, Folkert W Asselbergs, Marish I F J Oerlemans, Stefan Koudstaal, Frans H Rutten","doi":"10.2196/41248","DOIUrl":"10.2196/41248","url":null,"abstract":"<p><strong>Background: </strong>Research on the use of home telemonitoring data and adherence to it can provide new insights into telemonitoring for the daily management of patients with heart failure (HF).</p><p><strong>Objective: </strong>We described the use of a telemonitoring platform-including remote patient monitoring of blood pressure, pulse, and weight-and the use of the electronic personal health record. Patient characteristics were assessed in both adherent and nonadherent patients to weight transmissions.</p><p><strong>Methods: </strong>We used the data of the e-Vita HF study, a 3-arm parallel randomized trial performed in stable patients with HF managed in outpatient clinics in the Netherlands. In this study, data were analyzed from the participants in the intervention arm (ie, e-Vita HF platform). Adherence to weight transmissions was defined as transmitting weight ≥3 times per week for at least 42 weeks during a year.</p><p><strong>Results: </strong>Data from 150 patients (mean age 67, SD 11 years; n=37, 25% female; n=123, 82% self-assessed New York Heart Association class I-II) were analyzed. One-year adherence to weight transmissions was 74% (n=111). Patients adherent to weight transmissions were less often hospitalized for HF in the 6 months before enrollment in the study compared to those who were nonadherent (n=9, 8% vs n=9, 23%; P=.02). The percentage of patients visiting the personal health record dropped steadily over time (n=140, 93% vs n=59, 39% at one year). With univariable analyses, there was no significant correlation between patient characteristics and adherence to weight transmissions.</p><p><strong>Conclusions: </strong>Adherence to remote patient monitoring was high among stable patients with HF and best for weighing; however, adherence decreased over time. Clinical and demographic variables seem not related to adherence to transmitting weight.</p><p><strong>Trial registration: </strong>ClinicalTrials.gov NCT01755988; https://clinicaltrials.gov/ct2/show/NCT01755988.</p>","PeriodicalId":14706,"journal":{"name":"JMIR Cardio","volume":"7 ","pages":"e41248"},"PeriodicalIF":0.0,"publicationDate":"2023-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9929726/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9971905","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Patients' Experiences With the Fit of Virtual Atrial Fibrillation Care During the Pandemic: Qualitative Descriptive Study. 大流行期间虚拟房颤护理的患者体验:定性描述性研究
Q2 Medicine Pub Date : 2023-01-30 DOI: 10.2196/41548
Kathy L Rush, Lindsay Burton, Peter Loewen, Ryan Wilson, Sarah Singh, Lana Moroz, Jason G Andrade

Background: In-person health care has been the standard model of care delivery for patients with atrial fibrillation (AF). Despite the growing use of remote technology, virtual health care has received limited formal study in populations with AF. Understanding the virtual care experiences of patients in specialized AF clinics is essential to inform future planning of AF clinic care.

Objective: This qualitative descriptive study aimed to understand patients' virtual AF clinic care experiences during the COVID-19 pandemic.

Methods: Participants were recruited from a pool of patients who were receiving care from an AF clinic and who were enrolled in a larger survey study. A total of 8 virtual focus groups (n=30) were conducted in 2 waves between March 2021 and May 2021. Facilitators used a semistructured discussion guide to ask participants questions about their experiences of virtual care and the perceived quality of virtual care and technology support. Three team members initially open coded group data to create a preliminary coding framework. As the analysis progressed, with subsequent focus groups, the code clusters were refined.

Results: The participants were primarily male (21/30, 70%), aged ≥65 years (20/30, 67%), and college graduates (22/30, 73%). Patients found virtual care to be highly beneficial. Central to their experiences of virtual care was its fit or lack of fit with their health needs, which was integrally connected to communication effectiveness and their preferred virtual care future. Practical benefits included flexibility, convenience, and time and cost savings of virtual care. Virtual care fit occurred for small, quick, and mundane issues (eg, medication refills) but was suboptimal for new and more complex issues that patients thought warranted an in-person visit. Fit often reflected the effectiveness of communication between patient and provider and that of in-clinic follow-up. There was near-complete agreement among participants on the acceptability of virtual communication with their providers in addressing their needs, but this depended on adequate reciprocal communication. Without the benefit of in-person physical assessments, patients were uncertain and lacked confidence in communicating the needed, correct, and comprehensive information. Finally, participants described concerns related to ongoing virtual care with recommendations for their preferred future using a hybrid model of care and integrating patient-reported data (ie, blood pressure measurements) in virtual care delivery.

Conclusions: Virtual care from a specialty AF clinic provides practical benefits for patients, but they must be weighed against the need for virtual care's fit with patients' needs and problems. The stability and complexity of patients' health needs, their management, and their perceptions of communication effectiveness with provider

背景:面对面的医疗保健已经成为房颤(AF)患者护理的标准模式。尽管远程技术的使用越来越多,但虚拟医疗保健在房颤人群中的正式研究有限。了解房颤专科诊所患者的虚拟医疗体验对房颤诊所护理的未来规划至关重要。目的:本定性描述性研究旨在了解COVID-19大流行期间AF患者的虚拟临床护理体验。方法:参与者是从接受房颤门诊治疗的患者中招募的,这些患者参加了一项更大的调查研究。共8个虚拟焦点小组(n=30)于2021年3月至2021年5月分两波进行。主持人使用半结构化讨论指南向参与者询问他们对虚拟护理的体验以及对虚拟护理和技术支持的感知质量的问题。三个团队成员首先打开编码组数据,以创建一个初步的编码框架。随着分析的进展,在随后的焦点小组中,代码簇得到了细化。结果:参与者主要为男性(21/ 30,70 %),年龄≥65岁(20/ 30,67 %),大学毕业生(22/ 30,73 %)。患者发现虚拟护理非常有益。他们对虚拟护理的体验的核心是它是否符合他们的健康需求,这与沟通有效性和他们首选的虚拟护理未来有内在的联系。实际的好处包括灵活性、便利性以及虚拟护理的时间和成本节约。虚拟护理适合于小的、快速的、普通的问题(例如,药物补充),但不适用于新的和更复杂的问题,患者认为需要亲自就诊。契合度往往反映了医患沟通的有效性和门诊随访的有效性。与会者几乎完全同意在满足其需要方面与提供者进行虚拟通信是可以接受的,但这取决于充分的相互通信。没有面对面的身体评估,患者不确定,缺乏沟通所需的,正确的,全面的信息的信心。最后,参与者描述了他们对正在进行的虚拟护理的担忧,并建议他们在虚拟护理中使用混合护理模型和整合患者报告的数据(即血压测量)。结论:来自专业房颤诊所的虚拟护理为患者提供了实际的好处,但必须权衡虚拟护理是否适合患者的需求和问题。在决定预约模式时,必须考虑患者健康需求的稳定性和复杂性、他们的管理以及他们对与提供者和诊所沟通有效性的看法。通过使用混合模型和数据共享系统,患者对未来虚拟护理的建议具有优化匹配的潜力。
{"title":"Patients' Experiences With the Fit of Virtual Atrial Fibrillation Care During the Pandemic: Qualitative Descriptive Study.","authors":"Kathy L Rush,&nbsp;Lindsay Burton,&nbsp;Peter Loewen,&nbsp;Ryan Wilson,&nbsp;Sarah Singh,&nbsp;Lana Moroz,&nbsp;Jason G Andrade","doi":"10.2196/41548","DOIUrl":"https://doi.org/10.2196/41548","url":null,"abstract":"<p><strong>Background: </strong>In-person health care has been the standard model of care delivery for patients with atrial fibrillation (AF). Despite the growing use of remote technology, virtual health care has received limited formal study in populations with AF. Understanding the virtual care experiences of patients in specialized AF clinics is essential to inform future planning of AF clinic care.</p><p><strong>Objective: </strong>This qualitative descriptive study aimed to understand patients' virtual AF clinic care experiences during the COVID-19 pandemic.</p><p><strong>Methods: </strong>Participants were recruited from a pool of patients who were receiving care from an AF clinic and who were enrolled in a larger survey study. A total of 8 virtual focus groups (n=30) were conducted in 2 waves between March 2021 and May 2021. Facilitators used a semistructured discussion guide to ask participants questions about their experiences of virtual care and the perceived quality of virtual care and technology support. Three team members initially open coded group data to create a preliminary coding framework. As the analysis progressed, with subsequent focus groups, the code clusters were refined.</p><p><strong>Results: </strong>The participants were primarily male (21/30, 70%), aged ≥65 years (20/30, 67%), and college graduates (22/30, 73%). Patients found virtual care to be highly beneficial. Central to their experiences of virtual care was its fit or lack of fit with their health needs, which was integrally connected to communication effectiveness and their preferred virtual care future. Practical benefits included flexibility, convenience, and time and cost savings of virtual care. Virtual care fit occurred for small, quick, and mundane issues (eg, medication refills) but was suboptimal for new and more complex issues that patients thought warranted an in-person visit. Fit often reflected the effectiveness of communication between patient and provider and that of in-clinic follow-up. There was near-complete agreement among participants on the acceptability of virtual communication with their providers in addressing their needs, but this depended on adequate reciprocal communication. Without the benefit of in-person physical assessments, patients were uncertain and lacked confidence in communicating the needed, correct, and comprehensive information. Finally, participants described concerns related to ongoing virtual care with recommendations for their preferred future using a hybrid model of care and integrating patient-reported data (ie, blood pressure measurements) in virtual care delivery.</p><p><strong>Conclusions: </strong>Virtual care from a specialty AF clinic provides practical benefits for patients, but they must be weighed against the need for virtual care's fit with patients' needs and problems. The stability and complexity of patients' health needs, their management, and their perceptions of communication effectiveness with provider","PeriodicalId":14706,"journal":{"name":"JMIR Cardio","volume":"7 ","pages":"e41548"},"PeriodicalIF":0.0,"publicationDate":"2023-01-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9926347/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9301785","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Patient-Facing Clinical Decision Support for High Blood Pressure Control: Patient Survey. 面向患者的高血压控制临床决策支持:患者调查。
Q2 Medicine Pub Date : 2023-01-23 DOI: 10.2196/39490
David Dorr, Chris D'Autremont, Joshua E Richardson, Michelle Bobo, Christopher Terndrup, M J Dunne, Anthony Cheng, Robert Rope

Background: High blood pressure (HBP) affects nearly half of adults in the United States and is a major factor in heart attacks, strokes, kidney disease, and other morbidities. To reduce risk, guidelines for HBP contain more than 70 recommendations, including many related to patient behaviors, such as home monitoring and lifestyle changes. Thus, the patient's role in controlling HBP is crucial. Patient-facing clinical decision support (CDS) tools may help patients adhere to evidence-based care, but customization is required.

Objective: Our objective was to understand how to adapt CDS to best engage patients in controlling HBP.

Methods: We conducted a mixed methods study with two phases: (1) survey-guided interviews with a limited cohort and (2) a nationwide web-based survey. Participation in each phase was limited to adults aged between 18 and 85 years who had been diagnosed with hypertension. The survey included general questions that assessed goal setting, treatment priorities, medication load, comorbid conditions, satisfaction with blood pressure (BP) management, and attitudes toward CDS, and also a series of questions regarding A/B preferences using paired information displays to assess perceived trustworthiness of potential CDS user interface options.

Results: We conducted 17 survey-guided interviews to gather patient needs from CDS, then analyzed results and created a second survey of 519 adults with clinically diagnosed HBP. A large majority of participants reported that BP control was a high priority (83%), had monitored BP at home (82%), and felt comfortable using technology (88%). Survey respondents found displays with more detailed recommendations more trustworthy (56%-77% of them preferred simpler displays), especially when incorporating social trust and priorities from providers and patients like them, but had no differences in action taken.

Conclusions: Respondents to the survey felt that CDS capabilities could help them with HBP control. The more detailed design options for BP display and recommendations messaging were considered the most trustworthy yet did not differentiate perceived actions.

背景:高血压(HBP)影响了美国近一半的成年人,是心脏病发作、中风、肾脏疾病和其他疾病的主要因素。为了降低风险,HBP指南包含了70多条建议,其中包括许多与患者行为有关的建议,如家庭监测和生活方式的改变。因此,患者在控制血压中的作用是至关重要的。面向患者的临床决策支持(CDS)工具可以帮助患者坚持循证护理,但需要定制。目的:我们的目的是了解如何调整CDS以使患者最好地参与控制HBP。方法:我们进行了一项混合方法研究,分为两个阶段:(1)有限队列的调查指导访谈和(2)全国网络调查。每个阶段的参与仅限于年龄在18岁至85岁之间、被诊断患有高血压的成年人。调查包括评估目标设定、治疗优先级、药物负荷、合并症、血压(BP)管理满意度和对CDS的态度的一般问题,以及一系列关于使用配对信息显示的a /B偏好的问题,以评估潜在CDS用户界面选项的感知可信度。结果:我们进行了17次调查导向访谈,从CDS中收集患者需求,然后对结果进行分析,并对519名临床诊断为HBP的成年人进行了第二次调查。绝大多数参与者报告说,血压控制是高度优先的(83%),在家里监测过血压(82%),对使用技术感到舒服(88%)。调查受访者发现,更详细的建议更值得信赖(56%-77%的人更喜欢更简单的显示),特别是在纳入社会信任和来自提供者和患者的优先事项时,但采取的行动没有差异。结论:调查对象认为CDS功能可以帮助他们控制血压。BP显示和推荐信息的更详细的设计选项被认为是最值得信赖的,但不能区分感知行为。
{"title":"Patient-Facing Clinical Decision Support for High Blood Pressure Control: Patient Survey.","authors":"David Dorr,&nbsp;Chris D'Autremont,&nbsp;Joshua E Richardson,&nbsp;Michelle Bobo,&nbsp;Christopher Terndrup,&nbsp;M J Dunne,&nbsp;Anthony Cheng,&nbsp;Robert Rope","doi":"10.2196/39490","DOIUrl":"https://doi.org/10.2196/39490","url":null,"abstract":"<p><strong>Background: </strong>High blood pressure (HBP) affects nearly half of adults in the United States and is a major factor in heart attacks, strokes, kidney disease, and other morbidities. To reduce risk, guidelines for HBP contain more than 70 recommendations, including many related to patient behaviors, such as home monitoring and lifestyle changes. Thus, the patient's role in controlling HBP is crucial. Patient-facing clinical decision support (CDS) tools may help patients adhere to evidence-based care, but customization is required.</p><p><strong>Objective: </strong>Our objective was to understand how to adapt CDS to best engage patients in controlling HBP.</p><p><strong>Methods: </strong>We conducted a mixed methods study with two phases: (1) survey-guided interviews with a limited cohort and (2) a nationwide web-based survey. Participation in each phase was limited to adults aged between 18 and 85 years who had been diagnosed with hypertension. The survey included general questions that assessed goal setting, treatment priorities, medication load, comorbid conditions, satisfaction with blood pressure (BP) management, and attitudes toward CDS, and also a series of questions regarding A/B preferences using paired information displays to assess perceived trustworthiness of potential CDS user interface options.</p><p><strong>Results: </strong>We conducted 17 survey-guided interviews to gather patient needs from CDS, then analyzed results and created a second survey of 519 adults with clinically diagnosed HBP. A large majority of participants reported that BP control was a high priority (83%), had monitored BP at home (82%), and felt comfortable using technology (88%). Survey respondents found displays with more detailed recommendations more trustworthy (56%-77% of them preferred simpler displays), especially when incorporating social trust and priorities from providers and patients like them, but had no differences in action taken.</p><p><strong>Conclusions: </strong>Respondents to the survey felt that CDS capabilities could help them with HBP control. The more detailed design options for BP display and recommendations messaging were considered the most trustworthy yet did not differentiate perceived actions.</p>","PeriodicalId":14706,"journal":{"name":"JMIR Cardio","volume":"7 ","pages":"e39490"},"PeriodicalIF":0.0,"publicationDate":"2023-01-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9903181/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9167665","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
High-Throughput Assessment of Real-World Medication Effects on QT Interval Prolongation: Observational Study. 高通量评估真实世界药物对 QT 间期延长的影响:观察研究。
Q2 Medicine Pub Date : 2023-01-20 DOI: 10.2196/41055
Neal Yuan, Adam Oesterle, Patrick Botting, Sumeet Chugh, Christine Albert, Joseph Ebinger, David Ouyang
<p><strong>Background: </strong>Drug-induced prolongation of the corrected QT interval (QTc) increases the risk for Torsades de Pointes (TdP) and sudden cardiac death. Medication effects on the QTc have been studied in controlled settings but may not be well evaluated in real-world settings where medication effects may be modulated by patient demographics and comorbidities as well as the usage of other concomitant medications.</p><p><strong>Objective: </strong>We demonstrate a new, high-throughput method leveraging electronic health records (EHRs) and the Surescripts pharmacy database to monitor real-world QTc-prolonging medication and potential interacting effects from demographics and comorbidities.</p><p><strong>Methods: </strong>We included all outpatient electrocardiograms (ECGs) from September 2008 to December 2019 at a large academic medical system, which were in sinus rhythm with a heart rate of 40-100 beats per minute, QRS duration of <120 milliseconds, and QTc of 300-700 milliseconds, determined using the Bazett formula. We used prescription information from the Surescripts pharmacy database and EHR medication lists to classify whether a patient was on a medication during an ECG. Negative control ECGs were obtained from patients not currently on the medication but who had been or would be on that medication within 1 year. We calculated the difference in mean QTc between ECGs of patients who are on and those who are off a medication and made comparisons to known medication TdP risks per the CredibleMeds.org database. Using linear regression analysis, we studied the interaction of patient-level demographics or comorbidities on medication-related QTc prolongation.</p><p><strong>Results: </strong>We analyzed the effects of 272 medications on 310,335 ECGs from 159,397 individuals. Medications associated with the greatest QTc prolongation were dofetilide (mean QTc difference 21.52, 95% CI 10.58-32.70 milliseconds), mexiletine (mean QTc difference 18.56, 95% CI 7.70-29.27 milliseconds), amiodarone (mean QTc difference 14.96, 95% CI 13.52-16.33 milliseconds), rifaximin (mean QTc difference 14.50, 95% CI 12.12-17.13 milliseconds), and sotalol (mean QTc difference 10.73, 95% CI 7.09-14.37 milliseconds). Several top QT prolonging medications such as rifaximin, lactulose, cinacalcet, and lenalidomide were not previously known but have plausible mechanistic explanations. Significant interactions were observed between demographics or comorbidities and QTc prolongation with many medications, such as coronary disease and amiodarone.</p><p><strong>Conclusions: </strong>We demonstrate a new, high-throughput technique for monitoring real-world effects of QTc-prolonging medications from readily accessible clinical data. Using this approach, we confirmed known medications for QTc prolongation and identified potential new associations and demographic or comorbidity interactions that could supplement findings in curated databases. Our single-center results wo
背景:药物引起的校正 QT 间期(QTc)延长会增加发生 Torsades de Pointes(TdP)和心脏性猝死的风险。药物对 QTc 的影响已在对照环境中进行了研究,但在实际环境中可能无法很好地评估,因为药物的影响可能受患者人口统计学、合并症以及其他并发症的影响:我们展示了一种新的、高通量的方法,利用电子健康记录(EHR)和 Surescripts 药房数据库监测真实世界中的 QTc 延长药物以及人口统计学和合并症的潜在相互作用:我们纳入了一家大型学术医疗系统从2008年9月至2019年12月的所有门诊心电图(ECG),这些心电图均为窦性心律,心率为每分钟40-100次,QRS持续时间为结果:我们分析了 272 种药物对 159397 人的 310335 张心电图的影响。与最大 QTc 延长相关的药物有多非利特(平均 QTc 差 21.52,95% CI 10.58-32.70 毫秒)、美西律(平均 QTc 差 18.56,95% CI 7.70-29.27毫秒)、胺碘酮(平均QTc差值14.96,95% CI 13.52-16.33毫秒)、利福昔明(平均QTc差值14.50,95% CI 12.12-17.13毫秒)和索他洛尔(平均QTc差值10.73,95% CI 7.09-14.37毫秒)。利福昔明、乳果糖、西那卡西酮和来那度胺等几种最主要的 QT 延长药物以前并不为人所知,但其机理解释是合理的。人口统计学或合并症与许多药物(如冠心病和胺碘酮)的QTc延长之间存在显著的相互作用:我们展示了一种新的、高通量的技术,可从易于获取的临床数据中监测 QTc 延长药物在现实世界中的影响。利用这种方法,我们确认了已知药物对 QTc 延长的影响,并发现了潜在的新关联以及人口统计学或合并症的相互作用,这些都可以补充整理数据库中的发现。未来的多点研究将纳入更多的患者和心电图以及更精确的用药依从性和合并症数据,我们的单中心研究结果将受益于这些研究的进一步验证。
{"title":"High-Throughput Assessment of Real-World Medication Effects on QT Interval Prolongation: Observational Study.","authors":"Neal Yuan, Adam Oesterle, Patrick Botting, Sumeet Chugh, Christine Albert, Joseph Ebinger, David Ouyang","doi":"10.2196/41055","DOIUrl":"10.2196/41055","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;Drug-induced prolongation of the corrected QT interval (QTc) increases the risk for Torsades de Pointes (TdP) and sudden cardiac death. Medication effects on the QTc have been studied in controlled settings but may not be well evaluated in real-world settings where medication effects may be modulated by patient demographics and comorbidities as well as the usage of other concomitant medications.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Objective: &lt;/strong&gt;We demonstrate a new, high-throughput method leveraging electronic health records (EHRs) and the Surescripts pharmacy database to monitor real-world QTc-prolonging medication and potential interacting effects from demographics and comorbidities.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;We included all outpatient electrocardiograms (ECGs) from September 2008 to December 2019 at a large academic medical system, which were in sinus rhythm with a heart rate of 40-100 beats per minute, QRS duration of &lt;120 milliseconds, and QTc of 300-700 milliseconds, determined using the Bazett formula. We used prescription information from the Surescripts pharmacy database and EHR medication lists to classify whether a patient was on a medication during an ECG. Negative control ECGs were obtained from patients not currently on the medication but who had been or would be on that medication within 1 year. We calculated the difference in mean QTc between ECGs of patients who are on and those who are off a medication and made comparisons to known medication TdP risks per the CredibleMeds.org database. Using linear regression analysis, we studied the interaction of patient-level demographics or comorbidities on medication-related QTc prolongation.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;We analyzed the effects of 272 medications on 310,335 ECGs from 159,397 individuals. Medications associated with the greatest QTc prolongation were dofetilide (mean QTc difference 21.52, 95% CI 10.58-32.70 milliseconds), mexiletine (mean QTc difference 18.56, 95% CI 7.70-29.27 milliseconds), amiodarone (mean QTc difference 14.96, 95% CI 13.52-16.33 milliseconds), rifaximin (mean QTc difference 14.50, 95% CI 12.12-17.13 milliseconds), and sotalol (mean QTc difference 10.73, 95% CI 7.09-14.37 milliseconds). Several top QT prolonging medications such as rifaximin, lactulose, cinacalcet, and lenalidomide were not previously known but have plausible mechanistic explanations. Significant interactions were observed between demographics or comorbidities and QTc prolongation with many medications, such as coronary disease and amiodarone.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusions: &lt;/strong&gt;We demonstrate a new, high-throughput technique for monitoring real-world effects of QTc-prolonging medications from readily accessible clinical data. Using this approach, we confirmed known medications for QTc prolongation and identified potential new associations and demographic or comorbidity interactions that could supplement findings in curated databases. Our single-center results wo","PeriodicalId":14706,"journal":{"name":"JMIR Cardio","volume":"7 ","pages":"e41055"},"PeriodicalIF":0.0,"publicationDate":"2023-01-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9898836/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9212066","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Racial and Socioeconomic Differences in Heart Failure Hospitalizations and Telemedicine Follow-up During the COVID-19 Pandemic: Retrospective Cohort Study. COVID-19大流行期间心力衰竭住院和远程医疗随访的种族和社会经济差异:回顾性队列研究
Q2 Medicine Pub Date : 2022-11-28 DOI: 10.2196/39566
Zachary Hughes, Julia Simkowski, Parry Mendapara, Nicolas Fink, Sparsh Gupta, Quentin Youmans, Sadiya Khan, Jane Wilcox, R Kannan Mutharasan

Background: Low rates of heart failure (HF) hospitalizations were observed during the 2020 peak of the COVID-19 pandemic. Additionally, posthospitalization follow-up transitioned to a predominantly telemedicine model. It is unknown whether the shift to telemedicine impacted disparities in posthospitalization follow-up or HF readmissions.

Objective: The aim of this paper is to determine whether the shift to telemedicine impacted racial and ethnic as well as socioeconomic disparities in acute decompensated heart failure (ADHF) follow-up and HF readmissions. We additionally sought to investigate the impact of the COVID-19 pandemic on the severity of ADHF hospitalizations.

Methods: This was a retrospective cohort study of HF admissions across 8 participating hospitals during the initial peak of the COVID-19 pandemic (March 15 to June 1, 2020), compared to the same time frame in 2019. Patients were stratified by race, ethnicity, and median neighborhood income. Hospital and intensive care unit (ICU) admission rates, inpatient mortality, 7-day follow-up, and 30-day readmissions were assessed.

Results: From March 15, 2019, to June 1, 2020, there were 1162 hospitalizations for ADHF included in the study. There were significantly fewer admissions for ADHF in 2020, compared with 2019 (442 vs 720; P<.001). Patients in 2020 had higher rates of ICU admission, compared with 2019 (15.8% vs 11.1%; P=.02). This trend was seen across all subgroups and was significant for patients from the highest income quartile (17.89% vs 10.99%; P=.02). While there was a trend toward higher inpatient mortality in 2020 versus 2019 (4.3% vs 2.8%; P=.17), no difference was seen among different racial and socioeconomic groups. Telemedicine comprised 81.6% of 7-day follow-up in 2020, with improvement in 7-day follow-up rates (40.5% vs 29.6%; P<.001). Inequities in 7-day follow-up for patients from non-Hispanic Black racial backgrounds compared to those from non-Hispanic White backgrounds decreased during the pandemic. Additionally, those with telemedicine follow-up were less likely to be readmitted in 30 days when compared to no follow-up (13.8% vs 22.4%; P=.03).

Conclusions: There were no major differences in HF ICU admissions or inpatient mortality for different racial and socioeconomic groups during the COVID-19 pandemic. Inequalities in 7-day follow-up were reduced with the advent of telemedicine and decreased 30-day readmission rates for those who had telemedicine follow-up.

背景:在2020年COVID-19大流行高峰期,心力衰竭(HF)住院率较低。此外,住院后随访过渡到主要的远程医疗模式。目前尚不清楚向远程医疗的转变是否影响了住院后随访或心衰再入院的差异。目的:本文的目的是确定远程医疗的转变是否会影响急性失代偿性心力衰竭(ADHF)随访和再入院的种族和民族以及社会经济差异。我们还试图调查COVID-19大流行对ADHF住院严重程度的影响。方法:这是一项回顾性队列研究,将8家参与研究的医院在2019年COVID-19大流行的初始高峰期间(2020年3月15日至6月1日)的心衰入院情况与2019年同期进行比较。患者按种族、民族和社区收入中位数进行分层。评估医院和重症监护病房(ICU)住院率、住院死亡率、7天随访和30天再入院率。结果:2019年3月15日至2020年6月1日,研究纳入了1162例ADHF住院病例。与2019年相比,2020年ADHF入院人数明显减少(442人对720人;结论:在2019冠状病毒病大流行期间,不同种族和社会经济群体的心衰ICU住院率和住院死亡率无显著差异。随着远程医疗的出现,7天随访中的不平等现象有所减少,并且远程医疗随访患者的30天再入院率也有所下降。
{"title":"Racial and Socioeconomic Differences in Heart Failure Hospitalizations and Telemedicine Follow-up During the COVID-19 Pandemic: Retrospective Cohort Study.","authors":"Zachary Hughes,&nbsp;Julia Simkowski,&nbsp;Parry Mendapara,&nbsp;Nicolas Fink,&nbsp;Sparsh Gupta,&nbsp;Quentin Youmans,&nbsp;Sadiya Khan,&nbsp;Jane Wilcox,&nbsp;R Kannan Mutharasan","doi":"10.2196/39566","DOIUrl":"https://doi.org/10.2196/39566","url":null,"abstract":"<p><strong>Background: </strong>Low rates of heart failure (HF) hospitalizations were observed during the 2020 peak of the COVID-19 pandemic. Additionally, posthospitalization follow-up transitioned to a predominantly telemedicine model. It is unknown whether the shift to telemedicine impacted disparities in posthospitalization follow-up or HF readmissions.</p><p><strong>Objective: </strong>The aim of this paper is to determine whether the shift to telemedicine impacted racial and ethnic as well as socioeconomic disparities in acute decompensated heart failure (ADHF) follow-up and HF readmissions. We additionally sought to investigate the impact of the COVID-19 pandemic on the severity of ADHF hospitalizations.</p><p><strong>Methods: </strong>This was a retrospective cohort study of HF admissions across 8 participating hospitals during the initial peak of the COVID-19 pandemic (March 15 to June 1, 2020), compared to the same time frame in 2019. Patients were stratified by race, ethnicity, and median neighborhood income. Hospital and intensive care unit (ICU) admission rates, inpatient mortality, 7-day follow-up, and 30-day readmissions were assessed.</p><p><strong>Results: </strong>From March 15, 2019, to June 1, 2020, there were 1162 hospitalizations for ADHF included in the study. There were significantly fewer admissions for ADHF in 2020, compared with 2019 (442 vs 720; P<.001). Patients in 2020 had higher rates of ICU admission, compared with 2019 (15.8% vs 11.1%; P=.02). This trend was seen across all subgroups and was significant for patients from the highest income quartile (17.89% vs 10.99%; P=.02). While there was a trend toward higher inpatient mortality in 2020 versus 2019 (4.3% vs 2.8%; P=.17), no difference was seen among different racial and socioeconomic groups. Telemedicine comprised 81.6% of 7-day follow-up in 2020, with improvement in 7-day follow-up rates (40.5% vs 29.6%; P<.001). Inequities in 7-day follow-up for patients from non-Hispanic Black racial backgrounds compared to those from non-Hispanic White backgrounds decreased during the pandemic. Additionally, those with telemedicine follow-up were less likely to be readmitted in 30 days when compared to no follow-up (13.8% vs 22.4%; P=.03).</p><p><strong>Conclusions: </strong>There were no major differences in HF ICU admissions or inpatient mortality for different racial and socioeconomic groups during the COVID-19 pandemic. Inequalities in 7-day follow-up were reduced with the advent of telemedicine and decreased 30-day readmission rates for those who had telemedicine follow-up.</p>","PeriodicalId":14706,"journal":{"name":"JMIR Cardio","volume":" ","pages":"e39566"},"PeriodicalIF":0.0,"publicationDate":"2022-11-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9707616/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40480330","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Analyzing Public Conversations About Heart Disease and Heart Health on Facebook From 2016 to 2021: Retrospective Observational Study Applying Latent Dirichlet Allocation Topic Modeling. 分析2016年至2021年Facebook上关于心脏病和心脏健康的公众对话:应用潜在狄利克雷分配主题模型的回顾性观察研究
Q2 Medicine Pub Date : 2022-11-22 DOI: 10.2196/40764
Haoning Xue, Jingwen Zhang, Kenji Sagae, Brian Nishimine, Yoshimi Fukuoka

Background: Heart disease continues to be the leading cause of death in men and women in the United States. The COVID-19 pandemic has further led to increases in various long-term cardiovascular complications.

Objective: This study analyzed public conversations related to heart disease and heart health on Facebook in terms of their thematic topics and sentiments. In addition, it provided in-depth analyses of 2 subtopics with important practical implications: heart health for women and heart health during the COVID-19 pandemic.

Methods: We collected 34,885 posts and 51,835 comments spanning from June 2016 to June 2021 that were related to heart disease and health from public Facebook pages and groups. We used latent Dirichlet allocation topic modeling to extract discussion topics illuminating the public's interests and concerns regarding heart disease and heart health. We also used Linguistic Inquiry and Word Count (Pennebaker Conglomerates, Inc) to identify public sentiments regarding heart health.

Results: We observed an increase in discussions related to heart health on Facebook. Posts and comments increased from 3102 and 3632 in 2016 to 8550 (176% increase) and 14,617 (302% increase) in 2021, respectively. Overall, 35.37% (12,340/34,885) of the posts were created after January 2020, the start of the COVID-19 pandemic. In total, 39.21% (13,677/34,885) of the posts were by nonprofit health organizations. We identified 6 topics in the posts (heart health promotion, personal experiences, risk-reduction education, heart health promotion for women, educational information, and physicians' live discussion sessions). We identified 6 topics in the comments (personal experiences, survivor stories, risk reduction, religion, medical questions, and appreciation of physicians and information on heart health). During the pandemic (from January 2020 to June 2021), risk reduction was a major topic in both posts and comments. Unverified information on alternative treatments and promotional content was also prevalent. Among all posts, 14.91% (5200/34,885) were specifically about heart health for women centering on local event promotion and distinctive symptoms of heart diseases for women.

Conclusions: Our results tracked the public's ongoing discussions on heart disease and heart health on one prominent social media platform, Facebook. The public's discussions and information sharing on heart health increased over time, especially since the start of the COVID-19 pandemic. Various levels of health organizations on Facebook actively promoted heart health information and engaged a large number of users. Facebook presents opportunities for more targeted heart health interventions that can reach and engage diverse populations.

背景:心脏病仍然是美国男性和女性死亡的主要原因。COVID-19大流行进一步导致各种长期心血管并发症的增加。目的:本研究分析了Facebook上与心脏病和心脏健康相关的公共对话的主题和情绪。此外,它还深入分析了具有重要实际意义的两个子主题:妇女心脏健康和2019冠状病毒病大流行期间的心脏健康。方法:我们收集了2016年6月至2021年6月期间与心脏病和健康相关的34,885篇帖子和51,835条评论,这些评论来自公共Facebook页面和群组。我们使用潜在的Dirichlet分配主题建模来提取讨论主题,以阐明公众对心脏病和心脏健康的兴趣和关注。我们还使用了语言调查和字数统计(Pennebaker集团公司)来确定公众对心脏健康的看法。结果:我们观察到Facebook上与心脏健康相关的讨论有所增加。文章和评论分别从2016年的3102篇和3632篇增加到2021年的8550篇(增长176%)和14617篇(增长302%)。总体而言,35.37%(12,340/34,885)的职位是在2020年1月COVID-19大流行开始后创建的。共有39.21%(13677 / 34885)的职位是由非营利卫生组织提供的。我们在帖子中确定了6个主题(心脏健康促进、个人经历、降低风险教育、女性心脏健康促进、教育信息和医生现场讨论)。我们在评论中确定了6个主题(个人经历,幸存者故事,降低风险,宗教,医学问题,以及对医生和心脏健康信息的欣赏)。在大流行期间(2020年1月至2021年6月),降低风险是帖子和评论中的一个主要主题。关于替代疗法和宣传内容的未经证实的信息也很普遍。在所有帖子中,14.91%(5200/34,885)是专门关于妇女心脏健康的,主要集中在当地活动宣传和妇女心脏病的独特症状上。结论:我们的研究结果追踪了公众在一个著名的社交媒体平台Facebook上关于心脏病和心脏健康的持续讨论。公众对心脏健康的讨论和信息共享随着时间的推移而增加,特别是自COVID-19大流行开始以来。各级卫生组织在Facebook上积极推广心脏健康信息,吸引了大量用户。Facebook为更有针对性的心脏健康干预提供了机会,可以接触到不同的人群。
{"title":"Analyzing Public Conversations About Heart Disease and Heart Health on Facebook From 2016 to 2021: Retrospective Observational Study Applying Latent Dirichlet Allocation Topic Modeling.","authors":"Haoning Xue,&nbsp;Jingwen Zhang,&nbsp;Kenji Sagae,&nbsp;Brian Nishimine,&nbsp;Yoshimi Fukuoka","doi":"10.2196/40764","DOIUrl":"https://doi.org/10.2196/40764","url":null,"abstract":"<p><strong>Background: </strong>Heart disease continues to be the leading cause of death in men and women in the United States. The COVID-19 pandemic has further led to increases in various long-term cardiovascular complications.</p><p><strong>Objective: </strong>This study analyzed public conversations related to heart disease and heart health on Facebook in terms of their thematic topics and sentiments. In addition, it provided in-depth analyses of 2 subtopics with important practical implications: heart health for women and heart health during the COVID-19 pandemic.</p><p><strong>Methods: </strong>We collected 34,885 posts and 51,835 comments spanning from June 2016 to June 2021 that were related to heart disease and health from public Facebook pages and groups. We used latent Dirichlet allocation topic modeling to extract discussion topics illuminating the public's interests and concerns regarding heart disease and heart health. We also used Linguistic Inquiry and Word Count (Pennebaker Conglomerates, Inc) to identify public sentiments regarding heart health.</p><p><strong>Results: </strong>We observed an increase in discussions related to heart health on Facebook. Posts and comments increased from 3102 and 3632 in 2016 to 8550 (176% increase) and 14,617 (302% increase) in 2021, respectively. Overall, 35.37% (12,340/34,885) of the posts were created after January 2020, the start of the COVID-19 pandemic. In total, 39.21% (13,677/34,885) of the posts were by nonprofit health organizations. We identified 6 topics in the posts (heart health promotion, personal experiences, risk-reduction education, heart health promotion for women, educational information, and physicians' live discussion sessions). We identified 6 topics in the comments (personal experiences, survivor stories, risk reduction, religion, medical questions, and appreciation of physicians and information on heart health). During the pandemic (from January 2020 to June 2021), risk reduction was a major topic in both posts and comments. Unverified information on alternative treatments and promotional content was also prevalent. Among all posts, 14.91% (5200/34,885) were specifically about heart health for women centering on local event promotion and distinctive symptoms of heart diseases for women.</p><p><strong>Conclusions: </strong>Our results tracked the public's ongoing discussions on heart disease and heart health on one prominent social media platform, Facebook. The public's discussions and information sharing on heart health increased over time, especially since the start of the COVID-19 pandemic. Various levels of health organizations on Facebook actively promoted heart health information and engaged a large number of users. Facebook presents opportunities for more targeted heart health interventions that can reach and engage diverse populations.</p>","PeriodicalId":14706,"journal":{"name":"JMIR Cardio","volume":" ","pages":"e40764"},"PeriodicalIF":0.0,"publicationDate":"2022-11-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9683528/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40438111","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
The First National Program of Remote Cardiac Rehabilitation in Israel-Goal Achievements, Adherence, and Responsiveness in Older Adult Patients: Retrospective Analysis. 以色列第一个国家远程心脏康复项目——老年患者的目标成就、依从性和反应性:回顾性分析。
Q2 Medicine Pub Date : 2022-11-16 DOI: 10.2196/36947
Irene Nabutovsky, Daniel Breitner, Alexis Heller, Mickey Scheinowitz, Yarin Klempfner, Robert Klempfner

Background: Remote cardiac rehabilitation (RCR) after myocardial infarction is an innovative Israeli national program in the field of telecardiology. RCR is included in the Israeli health coverage for all citizens. It is generally accepted that telemedicine programs better apply to younger patients because it is thought that they are more technologically literate than are older patients. It has also previously been thought that older patients have difficulty using technology-based programs and attaining program goals.

Objective: The objectives of this study were as follows: to study patterns of physical activity, goal achievement, and improvement in functional capacity among patients undergoing RCR over 65 years old compared to those of younger patients; and to identify predictors of better adherence with the RCR program.

Methods: A retrospective study of patients post-myocardial infarction were enrolled in a 6-month RCR program. The activity of the patients was monitored using a smartwatch. The data were collected and analyzed by a special telemedicine platform. RCR program goals were as follows: 150 minutes of aerobic activity per week, 120 minutes of the activity in the target heart rate recommended by the exercise physiologist, and 8000 steps per day. Models were created to evaluate variables predicting adherence with the program.

Results: Out of 306 patients, 80 were older adults (mean age 70 years, SD 3.4 years). At the end of the program, there was a significant improvement in the functional capacity of all patients (P=.002). Specifically, the older adult group improved from a mean 8.1 (SD 2.8) to 11.2 (SD 12.6). The metabolic equivalents of task (METs) and final MET results were similar among older and younger patients. During the entire program period, the older adult group showed better achievement of program goals compared to younger patients (P=.03). Additionally, we found that younger patient age is an independent predictor of early dropout from the program and completion of program goals (P=.045); younger patients were more likely to experience early program dropout and to complete fewer program goals.

Conclusions: Older adult patients demonstrated better compliance and achievement of the goals of the remote rehabilitation program in comparison with younger patients. We found that older age is not a limitation but rather a predictor of better RCR program compliance and program goal achievement.

背景:心肌梗死后远程心脏康复(RCR)是以色列在心脏远程学领域的一项创新性国家项目。RCR被纳入以色列所有公民的医疗保险。人们普遍认为,远程医疗项目更适用于年轻患者,因为他们被认为比年长患者更懂技术。以前人们还认为,老年患者在使用基于技术的项目和实现项目目标方面存在困难。目的:本研究的目的如下:研究65岁以上RCR患者与年轻患者相比的身体活动模式、目标实现和功能能力改善;并确定更好地遵守RCR计划的预测因素。方法:对心肌梗死后患者进行为期6个月的RCR研究。通过智能手表监测患者的活动。数据收集和分析由一个专门的远程医疗平台。RCR计划的目标如下:每周进行150分钟的有氧运动,以运动生理学家推荐的目标心率进行120分钟的运动,每天8000步。建立模型来评估预测项目依从性的变量。结果:306例患者中,80例为老年人(平均年龄70岁,SD 3.4岁)。在项目结束时,所有患者的功能能力都有显著改善(P= 0.002)。具体而言,老年人组从平均8.1 (SD 2.8)改善到11.2 (SD 12.6)。任务代谢当量(METs)和最终MET结果在老年和年轻患者中相似。在整个项目期间,与年轻患者相比,老年人组表现出更好的项目目标实现情况(P=.03)。此外,我们发现年轻的患者年龄是早期退出计划和完成计划目标的独立预测因子(P= 0.045);年轻的患者更有可能经历早期的计划退出,完成更少的计划目标。结论:与年轻患者相比,老年患者表现出更好的依从性和实现远程康复计划的目标。我们发现年龄不是限制,而是更好的RCR计划依从性和计划目标实现的预测因子。
{"title":"The First National Program of Remote Cardiac Rehabilitation in Israel-Goal Achievements, Adherence, and Responsiveness in Older Adult Patients: Retrospective Analysis.","authors":"Irene Nabutovsky,&nbsp;Daniel Breitner,&nbsp;Alexis Heller,&nbsp;Mickey Scheinowitz,&nbsp;Yarin Klempfner,&nbsp;Robert Klempfner","doi":"10.2196/36947","DOIUrl":"https://doi.org/10.2196/36947","url":null,"abstract":"<p><strong>Background: </strong>Remote cardiac rehabilitation (RCR) after myocardial infarction is an innovative Israeli national program in the field of telecardiology. RCR is included in the Israeli health coverage for all citizens. It is generally accepted that telemedicine programs better apply to younger patients because it is thought that they are more technologically literate than are older patients. It has also previously been thought that older patients have difficulty using technology-based programs and attaining program goals.</p><p><strong>Objective: </strong>The objectives of this study were as follows: to study patterns of physical activity, goal achievement, and improvement in functional capacity among patients undergoing RCR over 65 years old compared to those of younger patients; and to identify predictors of better adherence with the RCR program.</p><p><strong>Methods: </strong>A retrospective study of patients post-myocardial infarction were enrolled in a 6-month RCR program. The activity of the patients was monitored using a smartwatch. The data were collected and analyzed by a special telemedicine platform. RCR program goals were as follows: 150 minutes of aerobic activity per week, 120 minutes of the activity in the target heart rate recommended by the exercise physiologist, and 8000 steps per day. Models were created to evaluate variables predicting adherence with the program.</p><p><strong>Results: </strong>Out of 306 patients, 80 were older adults (mean age 70 years, SD 3.4 years). At the end of the program, there was a significant improvement in the functional capacity of all patients (P=.002). Specifically, the older adult group improved from a mean 8.1 (SD 2.8) to 11.2 (SD 12.6). The metabolic equivalents of task (METs) and final MET results were similar among older and younger patients. During the entire program period, the older adult group showed better achievement of program goals compared to younger patients (P=.03). Additionally, we found that younger patient age is an independent predictor of early dropout from the program and completion of program goals (P=.045); younger patients were more likely to experience early program dropout and to complete fewer program goals.</p><p><strong>Conclusions: </strong>Older adult patients demonstrated better compliance and achievement of the goals of the remote rehabilitation program in comparison with younger patients. We found that older age is not a limitation but rather a predictor of better RCR program compliance and program goal achievement.</p>","PeriodicalId":14706,"journal":{"name":"JMIR Cardio","volume":" ","pages":"e36947"},"PeriodicalIF":0.0,"publicationDate":"2022-11-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9713616/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40688313","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
期刊
JMIR Cardio
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1